Swipe Left For English
9月16日，强生肿瘤创新疗法专题研讨会将于上海启幕。届时，您将有机会与强生肿瘤领域领导团队面对面交流，共同探讨创新治疗技术与精准医疗策略如何为实体瘤治疗开辟全新路径。
出席此次研讨会的J&J重磅嘉宾有：
Dan Wang
Head, Asia Pacific External Scientific Innovation
Jeff Infante
Global Head, Early Oncology R&D
Robert Radinsky
VP, Global Head, Oncology External Innovation
Stefan Hart
VP, Oncology External Innovation Asia Pacific
Ulrike Philippar
VP, Global Head of Oncology Discovery
Wei Wu
Principal Venture Investment
Yusri Elsayed
SVP, Global Head TA Oncology
Johan Verbeeck
VP Business Development Oncology
本次活动将于9月16日下午2:00至6:00举行，安排有主题演讲及专题讨论环节。活动结束后还将举办交流酒会，邀请来自中国生物科技、投资和产业、学术领域的杰出代表齐聚一堂，促进思想碰撞与深度交流。
申请现场参会
注：所有参会申请将经过内部审核后通过邮件确认获得参会资格
线上直播报名
注：直播仅对注册观众开放
期待在这个下午与您相聚，共享前沿洞见，深入探讨行业发展并为携手合作建立联系。
On September 16, theJohnson & Johnson Oncology Innovative Therapies Symposiumwill take place in Shanghai. You will have the opportunity to engage face-to-face with Johnson & Johnson Oncology leaders and explore how innovative treatment technologies and precision medicine strategies can open new pathways in solid-tumor treatment.
Our featured J&J speakers include:
Dan Wang
Head, Asia Pacific External Scientific Innovation
Jeff Infante
Global Head, Early Oncology R&D
Robert Radinsky
VP, Global Head, Oncology External Innovation
Stefan Hart
VP, Oncology External Innovation Asia Pacific
Ulrike Philippar
VP, Global Head of Oncology Discovery
Wei Wu
Principal Venture Investment
Yusri Elsayed
SVP, Global Head TA Oncology
Johan Verbeeck
VP Business Development Oncology
The program will take placefrom 2:00 to 6:00 PMand will include keynote presentations and a moderated panel discussion, followed by a networking reception that brings together China's biotech, investment, and academic communities.
On-site offline registration
Note: Attendance is by approval only.
Online LIVE Registration
Note: The livestream is available to registered attendees only.
We look forward to welcoming you for an afternoon of expertise, discussion, and meaningful connection.
热门跟贴